A peer-reviewed journal in the field of internal medicine. Impact Factor 7.6. ✉️ [email protected]

Sweden
Joined November 2012
New Review to read! One estimated glomerular filtration rate, many diseases. ➡️ What remains beyond filtration-based classification of chronic kidney disease? 🔗 doi.org/10.1111/joim.70175 #CKD #glomerularfiltration #kidneydisease #albuminuria #KDIGO #nephrology
17
JIM - Journal of Internal Medicine retweeted
Yet more data on the benefits of drinking tea ☕️ 👍 📸: onlinelibrary.wiley.com/doi/…
12
53
3
152
10,286
New Perspective to read! #Periodontitis and systemic disease: A clinical perspective. ➡️ Increasing evidence associates periodontitis with systemic inflammatory conditions, particularly atherosclerotic #cardiovascular disease. 🔗 doi.org/10.1111/joim.70176 #atherosclerosis
40
New Research Letter! Anti-Ku positivity in primary #Sjögren's disease is associated with a more severe disease course. ➡️Primary Sjögren’s disease is a common autoimmune disease with systemic manifestations in 40%–60% of patients. 🔗doi.org/10.1111/joim.70169 #autoimmune #AntiKu
2
5
8
348
New article! Habitual #tea consumption is associated with lower #cardiovascular disease risk. ➡️Tea consumption combined with non-smoking and high physical activity was associated with the lowest risk. 🔗doi.org/10.1111/joim.70172 #physicalactivity #smoking #teaconsumption
2
77
New Perspective! Interacting climatic, environmental, biologic and socio-economic drivers of the global #dengue expansion. ➡️Dengue is the most rapidly expanding mosquito-borne viral disease worldwide. ➡️Over 11,000 deaths in 2024. 🔗 doi.org/10.1111/joim.70174 #infectiousdisease
47
New review to read! Treatment of #hyperphagia and #obesity in Prader–Willi syndrome. ➡️ Studies of the first approved treatment of hyperphagia in PWS, have shown promising results, particularly in managing severe hyperphagia. 🔗 doi.org/10.1111/joim.70173 #PraderWillisyndrome
61
New review! #GLP-1 receptor agonists and serious adverse events. ➡️ Appraises evidence regarding seven serious adverse events linked to GLP-1 receptor agonists. ➡️ Evidence, uncertainty and clinical implications. 🔗doi.org/10.1111/joim.70170 #diabetesmellitus #obesity
72
New Editorial to read! Beyond maternal remission: Placental dysfunction in systemic lupus erythematosus pregnancy. 🔗doi.org/10.1111/joim.70171 👉Also, read the article it is commenting on: doi.org/10.1111/joim.70140 #SLE #placenta #pregnancy
103
New article! Employment status and occupation are associated with liver cirrhosis. ➡️ Routinely collected employment information may help identify groups who could benefit from earlier liver evaluation. 🔗doi.org/10.1111/joim.70166 #liver #cirrhosis #occupation #internalmedicine
82
The Journal of Internal Medicine congratulates the 2026 Nobel Prize laureates in Physiology or Medicine for their discoveries concerning light-gated ion channels and #optogenetics. ➡️The potential of optogenetics in AF in a previous article in JIM! doi.org/10.1111/joim.13654
68
Welcome to read the Editor´s Choice in October! ➡️Upcoming therapies for steatotic liver disease. ➡️Translating breakthroughs into clinical practice. 🔗doi.org/10.1111/joim.70143 #liver #MASLD
70
New review to read! #Vascular #Ehlers–#Danlos syndrome: A multidisciplinary clinical framework for early suspicion, emergency-safe management and lifelong care. 🔗doi.org/10.1111/joim.70165
1
87
New article to read! Routine versus standardized blood pressure measurements. ➡️Agreement and association with cardiovascular disease. 🔗doi.org/10.1111/joim.70164 #bloodpressure #cardiovasculardiseases #hypertension
88
New article! Cancer co-medication quality in older patients with polypharmacy. ➡️ A randomized controlled trial. ➡️ Pharmacist-led medication reviews substantially improved cancer and co-medication quality. 🔗doi.org/10.1111/joim.70161 #MedicationReview #CancerCare
67